Navigation Links
Scientists in Singapore and Europe to collaborate
Date:10/13/2011

HEIDELBERG -- Scientists in Singapore and Europe will have new avenues for scientific interaction, following a cooperation agreement between EMBO, its intergovernmental funding body, EMBC, and the government of Singapore. The agreement will allow Singapore scientists to participate in EMBO training programmes and activities. It also means that EMBO workshops and lectures can take place in Singapore. This is the first cooperation agreement of its kind between EMBO, EMBC and Singapore.

"EMBO promotes and encourages the development of the life sciences within Europe and beyond. We welcome the opportunity to ensure the mobility of scientists between Singapore and Europe and we look forward to the scientific collaboration that this agreement will bring," said EMBO Director Maria Leptin.

Chairman of the Singapore Agency for Science, Technology and Research (A*STAR), Mr Lim Chuan Poh, said that Singapore shared the same vision. "We are confident that this agreement will spur international collaborations in world-class scientific research, which will pave the way for new biomedical discoveries and global healthcare solutions."

A*STAR represented Singapore in negotiations. The agreement brings together major players in Singapore's biomedical research scene, namely A*STAR, the National University of Singapore (NUS) and the Nanyang Technological University (NTU).

New opportunities for scientific interaction

Under the agreement, scientists can apply for EMBO Short-Term and Long-Term Fellowships to work in Singapore or Europe. Scientists from Singapore can apply to the EMBO Young Investigator Programme, which provides outstanding young scientists with financial, academic and practical support to start up their first independent research laboratories.

Singapore and EMBO will also cooperate in the organization of an EMBO Workshop in Singapore, which will help to spark cross-disciplinary collaborations. The workshop organizers from Singapore and Europe can apply for funding for an EMBO Member or Young Investigator as plenary lecturer at their event. Other conferences in Singapore can also apply for the support of an EMBO Member or Young Investigator as speaker.

The cooperation agreement will run for three years.

Singapore and EMBO: a growing relationship

The cooperation agreement builds on a growing series of exchanges between Singapore and scientists associated with EMBO. Key EMBO Members based in Singapore include NTU President Professor Bertil Andersson; A*STAR Chief Scientist, Professor Sir David Lane; Chairman of A*STAR's Biomedical Research Council, Professor Sir George Radda; and NTU Professor of Biological Sciences and Chair of EMBO Council, Daniela Rhodes. Since 2005, there have been eight EMBO-funded events in Singapore, including a 2011 Plenary Lecture. In 2009, 12 EMBO Gold Medalists presented their work and held discussions with 300 researchers based in Singapore on a range of topics in developmental, cell and molecular biology.


'/>"/>
Contact: Suzanne Beveridge
communications@embo.org
European Molecular Biology Organization
Source:Eurekalert

Related medicine news :

1. Scientists Pinpoint Area of Brain That Fears Losing Money
2. Scientists Discover How HIV Is Transmitted Between Men
3. Prevention Is Key Research Goal for Premature Babies, Scientists Say
4. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
5. Scientists find donut-shaped structure of enzyme involved in energy metabolism
6. Neuroscientists reveal new links that regulate brain electrical activity
7. Two UCSF Scientists to Receive Prestigious Dementia Research Honor
8. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
9. Scientists Spot Genetic Fingerprints of Individual Cancers
10. Scientists Unravel Mysteries of Intelligence
11. MSU scientists develop more effective method of predicting lead-poisoning risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... Launching of the ... Instance Manager architecture, meeting the needs of multichannel growth and doubling the ... auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative flexibility ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, N.Y., ... for adherence to the highest standards of trauma, maternity, cancer and chronic obstructive ... president and CEO, Dr. Daniel Messina. , Among the recognitions, the American College ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... the Affordable Care Act. Dr. Botelho advocates for the mass media launching of ... gives people ongoing opportunities to share their unfortunate experiences; such a movement can ...
(Date:12/8/2016)... AR (PRWEB) , ... December 08, 2016 , ... ... insurance and financial planning services from offices headquartered in Little Rock, has initiated ... Pantry. , According to the National Foundation to End Senior Hunger, Arkansas ranks ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016 CANTEL MEDICAL CORP. (NYSE: CMD ... $0.45 per diluted share, on a 22.1% increase in sales ... 31, 2016. This compares with net income of $14,254,000, or ... first quarter ended October 31, 2015. Non-GAAP ... 31, 2016 to $21,323,000, or $0.51 per diluted share, compared ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... with cutting edge next-generation sequencing and bioinformatics expertise; AITbiotech Pte ... the Genome Institute of Singapore (GIS) ... joint venture between Novogene and AITbiotech – will establish a ... Singapore .   The new centre will ...
(Date:12/7/2016)... --  IQuity, Inc., a specialty diagnostic technology ... has been appointed to its Board of ... experience as CEO, COO, and Board Director for ... the molecular, clinical diagnostic, and medical device industries. ... within the pharmaceutical industry. His operational and commercial ...
Breaking Medicine Technology: